Bids Are Invited For Acquisition Of Medicines, By Direct Purchase, For The Pedro Ernesto University Hospital.

Pharmacological Group: Vasodilators And Sclerosants, Active Ingredient: Alprostadil, Alphacyclodextrin, Pharmaceutical Form: Lyophilic Powder For Injectable Solution, Concentration / Dosage: 20 Mcg, Unit: Mcg, Volume: N/A, Presentation: Ampoule, Accessory: N/A, Pharmacological Group: Mydriatics, Miotics And Cycloplegics, Active Ingredient: Brinzolamide, Pharmaceutical Form: Ophthalmic Solution, Concentration / Dosage: 1%, Unit: %, Volume: 5Ml, Presentation: Dropper Bottle, Pharmacological Group: Antineoplastics, Active Ingredient: Cyclophosphamide , Pharmaceutical Form: Dragee, Concentration / Dosage: 50, Unit: Mg, Presentation: N/A, Pharmacological Group: Anxiolytics And Hypnosedatives, Active Ingredient: Clobazam, Pharmaceutical Form: Tablet, Concentration / Dosage: 10, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Pharmacological Group: Non-Steroidal Anti-Inflammatory Agents, Active Ingredient: Colchicine, Concentration/Dosage: 0, 5, 11/10/2024, Pharmacological Group: Hypoglycemic Agents, Active Ingredient: Desmopressin, Pharmaceutical Form: Application Nasal, 1, Unit: Mg/Ml, Volume: 2.5Ml, Presentation: Bottle, Active Ingredient: Regular Human Insulin, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 100, Unit: Iu/Ml, Volume: 10Ml, Presentation : Vial-Ampule, Active Ingredient: Isosorbide Dinitrate, Pharmaceutical Form: Sublingual Tablet, Concentration / Dosage: 5, Active Ingredient: Sodium Methotrexate, Pharmaceutical Form: Lyophilized Powder For Injectable Solution Without Preservative, Concentration / Dosage: 500, Active Ingredient : Methotrexate, Concentration / Dosage: 2